HUMULIN N

Humulin N Adverse Events Reported to the FDA Over Time

How are Humulin N adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Humulin N, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Humulin N is flagged as the suspect drug causing the adverse event.

Most Common Humulin N Adverse Events Reported to the FDA

What are the most common Humulin N adverse events reported to the FDA?

Blood Glucose Increased	870 (6.29%)
Blood Glucose Decreased	454 (3.28%)
Drug Exposure During Pregnancy	344 (2.49%)
Drug Ineffective	278 (2.01%)
Hypoglycaemia	196 (1.42%)
Loss Of Consciousness	182 (1.32%)
Visual Acuity Reduced	170 (1.23%)
Fall	150 (1.08%)
Cerebrovascular Accident	149 (1.08%)
Blindness	142 (1.03%)
Blood Glucose Fluctuation	133 (.96%)
	Show More
Myocardial Infarction	132 (.95%)
Malaise	118 (.85%)
Dyspnoea	117 (.85%)
Feeling Abnormal	114 (.82%)
Cardiac Disorder	106 (.77%)
Dizziness	99 (.72%)
Hospitalisation	97 (.7%)
Hyperglycaemia	95 (.69%)
Renal Failure	94 (.68%)
Cataract	93 (.67%)
Incorrect Dose Administered	93 (.67%)
Cardiac Failure Congestive	86 (.62%)
Diabetes Mellitus Inadequate Contro...	86 (.62%)
Vomiting	85 (.61%)
Weight Decreased	83 (.6%)
Premature Baby	81 (.59%)
Eye Haemorrhage	78 (.56%)
Hypertension	76 (.55%)
Memory Impairment	75 (.54%)
Pain In Extremity	71 (.51%)
Blindness Unilateral	67 (.48%)
Headache	65 (.47%)
Asthenia	64 (.46%)
Convulsion	63 (.46%)
Death	62 (.45%)
Weight Increased	61 (.44%)
Abortion Spontaneous	60 (.43%)
Tremor	60 (.43%)
Fatigue	59 (.43%)
Medication Error	59 (.43%)
Hyperhidrosis	58 (.42%)
Arthralgia	57 (.41%)
Nausea	57 (.41%)
Oedema Peripheral	57 (.41%)
Pain	57 (.41%)
Arthritis	56 (.4%)
Glycosylated Haemoglobin Increased	54 (.39%)
Visual Impairment	54 (.39%)
Diabetic Retinopathy	52 (.38%)
Drug Dose Omission	52 (.38%)
Road Traffic Accident	52 (.38%)
Syncope	52 (.38%)
Pneumonia	51 (.37%)
Gait Disturbance	50 (.36%)
Renal Disorder	50 (.36%)
Diarrhoea	48 (.35%)
Chest Pain	47 (.34%)
Injection Site Pain	47 (.34%)
Vision Blurred	46 (.33%)
Blood Glucose Abnormal	43 (.31%)
Glaucoma	43 (.31%)
Confusional State	42 (.3%)
Hypoglycaemic Unconsciousness	42 (.3%)
Coma	41 (.3%)
Pruritus	41 (.3%)
Drug Hypersensitivity	39 (.28%)
Hypersensitivity	38 (.27%)
Infection	38 (.27%)
Depression	37 (.27%)
Hypoacusis	37 (.27%)
Urticaria	36 (.26%)
Depressed Level Of Consciousness	35 (.25%)
Pyrexia	35 (.25%)
Dehydration	34 (.25%)
Macular Degeneration	34 (.25%)
Asthma	33 (.24%)
Blood Pressure Decreased	33 (.24%)
Diabetic Ketoacidosis	33 (.24%)
Expired Drug Administered	33 (.24%)
Insomnia	33 (.24%)
Poor Quality Drug Administered	33 (.24%)
Fluid Retention	32 (.23%)
Hypoaesthesia	32 (.23%)
Urinary Tract Infection	32 (.23%)
Wrong Drug Administered	32 (.23%)
Blood Pressure Increased	31 (.22%)
Limb Injury	31 (.22%)
Stress	31 (.22%)
Amnesia	30 (.22%)
Hip Fracture	30 (.22%)
Anaemia	29 (.21%)
Eye Disorder	29 (.21%)
Hypoglycaemia Unawareness	29 (.21%)
Neuropathy Peripheral	29 (.21%)
Cardiac Failure	28 (.2%)
Mobility Decreased	28 (.2%)
Cataract Operation	27 (.2%)
Injection Site Haemorrhage	27 (.2%)
Retinal Haemorrhage	27 (.2%)
Skin Ulcer	27 (.2%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Humulin N, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Humulin N is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Humulin N

What are the most common Humulin N adverse events reported to the FDA?

Metabolic, Nutritional And Blood Ga...	1567 (11.32%)
Neurological	688 (4.97%)
Glucose Metabolism Disorders	525 (3.79%)
Vision	522 (3.77%)
Medication Errors	423 (3.06%)
Injuries	383 (2.77%)
Therapeutic And Nontherapeutic Effe...	351 (2.54%)
Chemical Injury And Poisoning	348 (2.51%)
Infections - Pathogen Unspecified	320 (2.31%)
Respiratory	248 (1.79%)
Gastrointestinal Signs	246 (1.78%)
	Show More
Epidermal And Dermal Conditions	227 (1.64%)
Coronary Artery	211 (1.52%)
Renal Disorders	200 (1.45%)
Joint	196 (1.42%)
Central Nervous System Vascular	190 (1.37%)
Musculoskeletal And Connective Tiss...	188 (1.36%)
Administration Site Reactions	177 (1.28%)
Physical Examination Topics	168 (1.21%)
Bone And Joint Injuries	161 (1.16%)
Therapeutic Procedures And Supporti...	152 (1.1%)
Mental Impairment	138 (1%)
Cardiac And Vascular Investigations	135 (.98%)
Allergic Conditions	127 (.92%)
Cardiac Disorder Signs	127 (.92%)
Procedural And Device Related Injur...	125 (.9%)
Neonatal And Perinatal Conditions	124 (.9%)
Movement Disorders	120 (.87%)
Heart Failures	116 (.84%)
Anxiety Disorders	114 (.82%)
Retina, Choroid And Vitreous Hemorr...	112 (.81%)
Abortions And Stillbirth	104 (.75%)
Bone And Joint Therapeutic Procedur...	104 (.75%)
Anterior Eye Structural Change, Dep...	96 (.69%)
Ocular Hemorrhages And Vascular	83 (.6%)
Skin Appendage Conditions	81 (.59%)
Gastrointestinal Motility And Defec...	80 (.58%)
Bacterial Infectious	79 (.57%)
Peripheral Neuropathies	79 (.57%)
Vascular Hypertensive	78 (.56%)
Cardiac Arrhythmias	77 (.56%)
Electrolyte And Fluid Balance Condi...	77 (.56%)
Muscle	75 (.54%)
Arteriosclerosis, Stenosis, Vascula...	74 (.53%)
Bronchial Disorders	74 (.53%)
Fatal Outcomes	73 (.53%)
Cardiac Therapeutic Procedures	72 (.52%)
Headaches	70 (.51%)
Appetite And General Nutritional	68 (.49%)
Seizures	68 (.49%)
Eye	67 (.48%)
Eye Therapeutic Procedures	67 (.48%)
Deliria	65 (.47%)
Ocular Structural Change, Deposit A...	64 (.46%)
Lifestyle Issues	62 (.45%)
Hepatic And Hepatobiliary	60 (.43%)
Musculoskeletal And Connective Tiss...	58 (.42%)
Diabetic Complications	57 (.41%)
Vascular Therapeutic Procedures	55 (.4%)
Hearing	50 (.36%)
Psychiatric	50 (.36%)
Glaucoma And Ocular Hypertension	48 (.35%)
Viral Infectious	46 (.33%)
Decreased And Nonspecific Blood Pre...	45 (.33%)
Sleep Disorders	44 (.32%)
Depressed Mood Disorders	43 (.31%)
Oral Soft Tissue Conditions	43 (.31%)
Tissue	43 (.31%)
Angiedema And Urticaria	41 (.3%)
Body Temperature Conditions	41 (.3%)
Vascular	40 (.29%)
Skin And Subcutaneous Tissue	39 (.28%)
Bone Disorders	36 (.26%)
Renal And Urinary Tract Investigati...	35 (.25%)
Gastrointestinal Neoplasms Malignan...	33 (.24%)
Mood Disorders	33 (.24%)
Anemias Nonhemolytic And Marrow Dep...	32 (.23%)
Exocrine Pancreas Conditions	32 (.23%)
Thyroid Gland	32 (.23%)
Water, Electrolyte And Mineral	32 (.23%)
Hematology Investigations	31 (.22%)
Myocardial	31 (.22%)
Hematological And Lymphoid Tissue T...	30 (.22%)
Breast Neoplasms Malignant And Unsp...	29 (.21%)
Disturbances In Thinking	29 (.21%)
Miscellaneous And Site Unspecified ...	28 (.2%)
Lipid Analyses	27 (.2%)
Urinary Tract Signs	27 (.2%)
Embolism And Thrombosis	26 (.19%)
Maternal Complications Of Labour An...	26 (.19%)
Ocular Infections, Irritations And ...	26 (.19%)
Suicidal And Self-injurious Behavio...	25 (.18%)
Salivary Gland Conditions	24 (.17%)
Renal And Urinary Tract Therapeutic...	23 (.17%)
Gastrointestinal Conditions	22 (.16%)
Neonatal Respiratory	22 (.16%)
Acid-base	21 (.15%)
Immunology And Allergy	20 (.14%)
Lower Respiratory Tract Disorders	20 (.14%)
Respiratory And Mediastinal Neoplas...	20 (.14%)
Maternal Complications Of Pregnancy	19 (.14%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Humulin N, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Humulin N is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.